DNA Damage Response Targeting Therapeutics (beyond PARP inhibitors) Market by Target Disease Indication, Therapeutic Area, Target Molecule (APE1/Ref-1, Casein Kinase 2, CHK-1, C-Tak, DHODH, MAPKAPK2, p53, and WEE 1), Type of Molecule (Biologics and Small Molecule), Route of Administration, and by Key Geographical Regions (US, Canada, Denmark, France, Germany, Italy, Spain, UK, Australia, Singapore, and South Korea): Industry Trends and Global Forecasts, 2021-2030